- Home
- ELDN vs BNY Comparison
ELDN vs BNY Comparison
Compare ELDN & BNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- BNY
- Stock Information
- Founded
- ELDN 2004
- BNY 2001
- Country
- ELDN United States
- BNY United States
- Employees
- ELDN N/A
- BNY N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- BNY Trusts Except Educational Religious and Charitable
- Sector
- ELDN Health Care
- BNY Finance
- Exchange
- ELDN Nasdaq
- BNY Nasdaq
- Market Cap
- ELDN 202.4M
- BNY 232.4M
- IPO Year
- ELDN N/A
- BNY N/A
- Fundamental
- Price
- ELDN $2.63
- BNY $9.52
- Analyst Decision
- ELDN Strong Buy
- BNY
- Analyst Count
- ELDN 2
- BNY 0
- Target Price
- ELDN $12.50
- BNY N/A
- AVG Volume (30 Days)
- ELDN 1.0M
- BNY 52.7K
- Earning Date
- ELDN 08-14-2025
- BNY 01-01-0001
- Dividend Yield
- ELDN N/A
- BNY 3.93%
- EPS Growth
- ELDN N/A
- BNY N/A
- EPS
- ELDN 0.21
- BNY N/A
- Revenue
- ELDN N/A
- BNY N/A
- Revenue This Year
- ELDN N/A
- BNY N/A
- Revenue Next Year
- ELDN N/A
- BNY N/A
- P/E Ratio
- ELDN $12.40
- BNY N/A
- Revenue Growth
- ELDN N/A
- BNY N/A
- 52 Week Low
- ELDN $2.38
- BNY $8.60
- 52 Week High
- ELDN $5.54
- BNY $10.80
- Technical
- Relative Strength Index (RSI)
- ELDN 36.28
- BNY 45.70
- Support Level
- ELDN $2.54
- BNY $9.32
- Resistance Level
- ELDN $2.82
- BNY $9.72
- Average True Range (ATR)
- ELDN 0.21
- BNY 0.11
- MACD
- ELDN -0.08
- BNY 0.02
- Stochastic Oscillator
- ELDN 20.00
- BNY 30.30
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About BNY BlackRock New York Municipal Income Trust
Blackrock NY Municipal Income Tr investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.